H1-5

H1-5 (H1.5/H1b) is a somatic linker histone that organizes higher-order chromatin structure and acts as a locus-specific transcriptional repressor in differentiated cells (PMID:22956909, PMID:38530350). It is enriched at the nuclear periphery in association with compacted DNA, and in differentiated (but not embryonic stem) cells it binds defined genic and intergenic domains—preferentially membrane-related gene families—where its presence is required for recruitment of SIRT1, enrichment of repressive H3K9me2, and chromatin compaction; depletion increases chromatin accessibility, deregulates gene expression, and slows cell growth (PMID:22956909, PMID:38530350). H1-5 directs gene silencing through cooperation with sequence-specific factors, repressing MyoD together with the homeoprotein MSX1 to block muscle differentiation (PMID:15192231) and acting downstream of FOXM1 to bind and repress differentiation-gene promoters in epidermal stem cells, thereby balancing self-renewal against differentiation (PMID:39019868). Beyond steady-state chromatin, it binds DNA over short-exon splice sites and slows RNA polymerase II near 3' splice sites to promote exon inclusion, coupling chromatin to alternative splicing (PMID:31076740), and it directly interacts with CENP-A nucleosomes at centromeres where it is required for α-satellite transcription, new CENP-A loading, and mitotic fidelity (PMID:41521667). H1-5 activity is regulated by cell-cycle, site-specific phosphorylation: GSK-3 phosphorylates Thr10 on chromatin-bound H1.5 from prometaphase to telophase, and Ras-AKT signaling suppresses this mark via MDM2-dependent GSK3 degradation to promote glioma growth (PMID:19136008, PMID:31307224). In disease contexts it has been linked to oncogenic transcription, upregulating CSF2 in basal-like breast cancer to drive tumorigenicity (PMID:34746019).

1. 1997 Medium

   Established that the linker histone H1b has intrinsic DNA-sequence selectivity rather than acting only as a generic chromatin compactor, and that its phosphorylation tracks active genome processes.

   Evidence In vitro binding assays comparing affinity for H3.2 vs H3.3 Omega elements, and pharmacological inhibition of transcription/replication with pH1b quantification in mouse fibroblasts

   PMID:9079620 PMID:9182532

   Open questions at the time

   • In vitro sequence preference not validated genome-wide
   • Kinase responsible for transcription/replication-linked phosphorylation not identified
   • Functional consequence of H3.2 gene binding in vivo untested
2. 2004 High

   Showed that H1-5 represses specific genes by partnering with a sequence-specific transcription factor, defining a targeted rather than purely structural role.

   Evidence Co-IP, ChIP, and functional differentiation assays of MSX1–H1b at the MyoD locus in cell culture and Xenopus animal caps

   PMID:15192231

   Open questions at the time

   • Whether MSX1 recruits H1b or vice versa unresolved
   • Generality beyond MyoD unknown at the time
   • No structural basis for the interaction
3. 2004 Medium

   Revealed an unexpected extracellular role: monoubiquitinated H1B is secreted and required for HRF-mediated antiviral protection, extending H1-5 function beyond chromatin.

   Evidence siRNA silencing of H1B in HRF+ CD4+ T cells with antiviral activity assays on supernatants and anti-ubiquitin Western blots

   PMID:15610014

   Open questions at the time

   • Mechanism of secretion and ubiquitination not defined
   • Single-system observation not independently confirmed
   • Molecular target of secreted H1B in antiviral activity unknown
4. 2009 Medium

   Defined H1.5 as a phosphorylation-regulated histone with distinct interphase and mitotic phosphosites, linking specific modifications to replication, transcription, and mitotic chromatin states.

   Evidence Phosphosite-specific antibodies and immunofluorescence in synchronized HeLa cells with staurosporine and replication/transcription marker colocalization

   PMID:19609548

   Open questions at the time

   • Kinases for Ser17/Ser172 not identified
   • Functional consequence of each phosphosite not tested
   • Antibody-based localization without orthogonal confirmation
5. 2008 High

   Identified GSK-3 as the writer of the mitotic Thr10 mark, placing H1.5 phosphorylation under a defined kinase and excluding alternative mitotic kinases.

   Evidence In vitro kinase assays with GSK-3, CDK1/cyclinB, CDK5/p35 plus phosphospecific immunofluorescence and GSK-3 inhibition in HeLa cells

   PMID:19136008

   Open questions at the time

   • Downstream effect of Thr10ph on chromatin function not established here
   • Upstream control of GSK-3 toward H1.5 unknown
   • Whether Thr10ph alters DNA/nucleosome binding untested
6. 2012 High

   Provided the genome-wide mechanistic picture: H1.5 binding in differentiated cells nucleates a repressive SIRT1/H3K9me2 compaction module at specific gene families.

   Evidence ChIP-seq of H1.5 with siRNA knockdown and ChIP for SIRT1/H3K9me2, chromatin accessibility, expression and growth assays in human cells

   PMID:22956909

   Open questions at the time

   • Order of recruitment of H1.5, SIRT1, H3K9me2 not resolved
   • Why ESCs lack H1.5 binding unexplained
   • Direct vs indirect dependence of SIRT1 on H1.5 not separated
7. 2013 Medium

   Mapped H1.5 within the broader linker-histone repertoire, showing depletion from active/CpG-dense regions and enrichment in repressive domains, implicating it in 3D genome organization.

   Evidence DamID genome-wide mapping of all five somatic H1 subtypes in human lung fibroblasts

   PMID:23746450

   Open questions at the time

   • Functional consequence of repressive-domain marking not tested
   • Subtype-specific contribution not isolated by perturbation
   • Relationship to nuclear-periphery localization not directly linked
8. 2016 Medium

   Traced H1.5's higher chromatin-binding affinity to a single residue near the globular/C-terminal junction, providing a molecular determinant of variant-specific behavior.

   Evidence FRAP exchange-rate measurements with in vitro mutagenesis and cell-cycle analysis after overexpression

   PMID:26912777

   Open questions at the time

   • Affinity difference not connected to a downstream function
   • Overexpression showed no cell-cycle effect, leaving phenotype unclear
   • Single-residue effect not tested in chromatin context genome-wide
9. 2019 High

   Extended H1.5 function to co-transcriptional RNA processing, showing it controls alternative splicing by stalling RNAP II at splice sites of short exons.

   Evidence ChIP-seq of H1.5 at splice sites, siRNA knockdown, RT-PCR for exon inclusion, and RNAP II ChIP in human lung fibroblasts

   PMID:31076740

   Open questions at the time

   • Mechanism by which H1.5 stalls RNAP II not defined
   • Whether splicing role depends on its repressive partners unknown
   • Spliceosome interplay not characterized
10. 2019 Medium

    Placed H1.5-T10 phosphorylation in an oncogenic signaling axis, showing Ras-AKT-MDM2 suppresses the mark to relieve repression of Ras target genes and promote glioma growth.

    Evidence Ras/AKT transfection with phospho-H1.5-T10 Western blot, growth/migration assays, and ChIP/qRT-PCR for downstream genes

    PMID:31307224

    Open questions at the time

    • Direct binding of H1.5-T10ph to target promoters vs indirect effect not separated
    • GSK3 degradation mechanism by MDM2 not structurally defined
    • Findings restricted to glioma model
11. 2021 Medium

    Demonstrated a gene-activating, pro-tumorigenic role in breast cancer, contrasting with H1.5's repressive functions elsewhere.

    Evidence ChIP at CSF2 promoter, knockdown with colony/mammosphere/tumorigenesis assays in basal-like breast cancer cells

    PMID:34746019

    Open questions at the time

    • How a linker histone activates CSF2 not mechanistically explained
    • Cofactors at the CSF2 promoter not identified
    • Context-dependence vs repressive role unresolved
12. 2024 Medium

    Positioned H1B in a FOXM1-driven self-renewal/differentiation circuit, showing it is a transcriptional effector repressing differentiation genes in epidermal stem cells.

    Evidence scRNA-seq, ChIP for FOXM1→H1B promoter and H1B→differentiation-gene promoters, and enforced FOXM1 expression

    PMID:39019868

    Open questions at the time

    • Whether H1B repression uses the SIRT1/H3K9me2 module here untested
    • Direct FOXM1–H1B regulatory step vs indirect not fully isolated
    • In vivo requirement not established
13. 2024 Medium

    Established universal nuclear-periphery enrichment and variant-specific, non-redundant chromatin roles distinguishing H1.5 from H1.2.

    Evidence Super-resolution imaging and siRNA knockdown of H1 variants across multiple human cell lines

    PMID:38530350

    Open questions at the time

    • Molecular basis of variant-specific effects not defined
    • Why H1.5 KD does not globally decompact unexplained
    • Periphery-tethering mechanism unknown
14. 2025 High

    Identified a direct centromeric function: H1.5 binds CENP-A nucleosomes and is required for α-satellite transcription, CENP-A loading, and mitotic integrity.

    Evidence In vitro binding to CENP-A mononucleosomes, immunofluorescence, ChIP, and siRNA knockdown with CENP-A loading and mitotic-defect readouts

    PMID:41521667

    Open questions at the time

    • Structural basis of H1.5–CENP-A interaction not solved
    • How H1.5 promotes α-satellite transcription mechanistically unclear
    • Relationship to Thr10 mitotic phosphorylation not linked

• How a single linker histone reconciles opposing context-dependent outputs—peripheral compaction and repression, RNAP II stalling for splicing, centromeric CENP-A support, and gene activation in cancer—remains unresolved.
• No unifying model linking phosphorylation/ubiquitination state to functional switching
• Direct interactome at distinct loci not comprehensively defined
• Structural mechanism of CENP-A and splice-site DNA recognition unknown